logo

For the Inventor, By the Inventor

Fitzroy, Australia

Genetic Technologies Limited

USPTO Granted Patents = 13

% Expired Patents = 76.9



Trademarks = 4

Forward Citations = 35

Loading Chart...
Loading Chart...

19 inventors (with patents filed for the assignee):

goldMedal Richard Allman (6 out of 9 patents)

silverMedal Debbie Mantzaris (4 out of 4 patents)

bronzeMedal Craig Matthew Lewis (3 out of 7 patents)

4.  Eduardo Vom (3 out of 17 patents)

5.  David A Hinds (2 out of 4 patents)

6.  Ralph Michael Bohmer (2 out of 3 patents)

7.  Gillian Sue Dite (1 out of 1 patent)

8.  Nicholas Mark Murphy (1 out of 1 patent)

9.  Bryan Walser (1 out of 9 patents)

10.  Nila Patil (1 out of 5 patents)

11.  David R Cox (1 out of 20 patents)

12.  Anthony J Berno (1 out of 12 patents)

13.  Joseph Frederick Williamson (1 out of 3 patents)

14.  John Anthony Millman (1 out of 3 patents)

15.  Nicola Charlotte Andrews (1 out of 1 patent)


13 patents:

1. 11257569 - Methods of assessing risk of developing a severe response to coronavirus infection (2022-02-22),
2. 11072830 - Methods for breast cancer risk assessment (2021-07-27),
3. 11031098 - Computer systems and methods for genomic analysis (2021-06-08),
4. 10920279 - Method for modifying a treatment regimen of a human female subject (2021-02-16),
5. 10683549 - Methods for assessing risk of developing breast cancer (2020-06-16),
6. 9447467 - Methods for obtaining fetal genetic material (2016-09-20),
7. 9078642 - Biological sampling device (2015-07-14),
8. 8827923 - Biological sampling device (2014-09-09),
9. 8734364 - Device and method for obtaining a biological sample (2014-05-27),
10. 8394582 - Identification of fetal DNA and fetal cell markers in maternal plasma or serum (2013-03-12),
11. 8315816 - Methods of genetic analysis involving the amplification of complementary duplicons (2012-11-20),
12. 7785898 - Maternal antibodies as fetal cell markers to identify and enrich fetal cells from maternal blood (2010-08-31),
13. 7615342 - ACTN3 genotype screen for athletic performance (2009-11-10),
Company Overview
Genetic Technologies Limited is an innovative biotechnology company based in Fitzroy, Australia, specializing in genetic testing and diagnostics. The organization focuses on developing advanced solutions for personalized medicine, particularly in the areas of cancer risk assessment and reproductive health. By leveraging proprietary technologies, Genetic Technologies aims to enhance patient outcomes through accurate genetic insights, contributing to the evolving landscape of healthcare and precision medicine.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

13 Patents

#1 in Fitzroy

#294 in Australia

#45,081 in the World

Fitzroy, AU
Fitzroy, Australia

Genetic Technologies Limited

Forward Citations = 35

19 inventors:

goldMedal Richard Allman (6 out of 9 patents)

silverMedal Debbie Mantzaris (4 out of 4 patents)

bronzeMedal Craig Matthew Lewis (3 out of 7 patents)

4.  Eduardo Vom (3 out of 17 patents)

5.  David A Hinds (2 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Genetic Technologies Limited. Retrieved from https://idiyas.com/company/genetic-technologies

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…